SCH-58261

Source: Wikipedia, the free encyclopedia.
SCH-58261
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine
JSmol)
  • c1ccccc1CCN1N=CC2=C1N=C(N)N3C2=NC(C4=CC=CO4)=N3
  • InChI=1S/C18H15N7O/c19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14/h1-7,10-11H,8-9H2,(H2,19,22) checkY
  • Key:UTLPKQYUXOEJIL-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

SCH-58261 is a

neuroprotective effects in a variety of animal models,[8][9][10][11][12][13] and has been investigated as a possible treatment for Parkinson's disease.[14][15]

See also

References

  1. PMID 8632302
    .
  2. PMID 32770138
    .
  3. S2CID 21130714
    .
  4. S2CID 26570997
    .
  5. PMID 10742303
    .
  6. S2CID 39153884
    .
  7. S2CID 36219448
    .
  8. S2CID 34804980
    .
  9. PMID 11880527
    .
  10. S2CID 26319608
    .
  11. PMID 17483693
    .
  12. PMID 19940169
    .
  13. PMID 31103616
    .
  14. PMID 11319241
    .
  15. S2CID 26841529
    .
cardiovascular system is a stub. You can help Wikipedia by expanding it.

drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SCH-58261&oldid=1119898061"